Researchers find psilocybin improved the anxiety and depression of terminal cancer patients for up to six months.
The study is considered a first step in restoring the hallucinogen's respectability.The psychedelic drug psilocybin, the active ingredient in "magic mushrooms," can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported Monday.
A single modest dose of the hallucinogen, whose reputation was severely tarnished by widespread nonmedical use in the psychedelic '60s and ethical lapses by researchers such as Timothy Leary, can improve patients' functioning for as long as six months, allowing them to spend their last days with more peace, researchers said.
The research was a pilot study involving only 12 patients, but it is viewed as a first step in restoring the drug to respectability.
via 'Magic mushrooms' ingredient beneficial to cancer patients, report says - latimes.com.